The International Neuromodulation Society

The Fastest-Growing, Worldwide Multidisciplinary Body Devoted to Building Knowledge of Neuromodulation

The International Neuromodulation Society (INS) is a non-profit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation – the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body. The San Francisco-based INS was formed in 1989 and educates and promotes the field through meetings, its peer-reviewed journal Neuromodulation: Technology at the Neural Interface, explanatory content, and chapter websites. The INS also provides information for patients and produces rolling news briefs about this rapidly evolving field.

The INS Peer-Reviewed Journal – 8 Issues a Year

The INS journal Neuromodulation: Technology at the Neural Interface has a growing Impact Factor and is indexed in Index Medicus, MEDLINE and Pubmed from its first issue in 1998. Members may log in to the members-only section to read the journal online.

journal cover

+Submit a Manuscript.+

What is Neuromodulation?

Medical Professionals can learn about various considerations concerning neuromodulation and clinic contacts. Once your preliminary questions have been answered, please use the Contact Us facility to find out more and to discuss specific objectives. Others may simply wish to join the INS and one of its related chapter societies, please use the Membership Application.

Clinical trials that involve a wide range of emerging neuromodulation approaches are listed on our Research page. Neuromodulation clinical trials address symptom control through nerve stimulation in such condition categories as:

If you are not a medical professional and you are searching for information about neuromodulation and how these types of treatment could benefit a specific condition such as treatment-resistant headache or other chronic pain syndromes, you may find the sections titled Therapies, About Neuromodulation or FAQs particularly helpful.

Members may log in and visit the members-only section’s Global Discussion Forum

Breaking News Share

Sydney-Area Pain Patient Discusses Use of Neuromodulation

May 25, 2019 - A news feature profiles an ex-Army infantryman in Australia who for the past three years has used spinal cord stimulation to manage chronic pain symptoms from a back injury in the 1980s. In the coverage, International Neuromodulation Society (INS) 14th World Congress chair Dr. Marc Russo comments about the therapy. In addition, INS 14th World Congress Public Event chair Dr. Nick Christelis was interviewed on an afternoon ABC radio program in Melbourne May 22 about neuromodulation therapy and pain treatment, as well as in an article in the Melbourne-area Herald Sun. (ABC Radio)

Government Agency Announces Funding for Noninvasive Brain-Machine Interface Projects

May 21, 2019 - Six research programs have received funding in the latest round of DARPA grants under its Next-Generation Nonsurgical Neurotechnology (N3) program, which is designed to support research into high-resolution, bidirectional brain-machine interfaces intended to allow service members or mission commanders to function in dynamic machine-influenced operations that unfold at rapid speed. (

Noninvasive Neurostimulation Company Receives $50 Million Funding Round

May 21, 2019 - Cala Health has raised $50 million in private funding before the launch of its weaable neurostimulation device to address hand tremor in essential tremor patients. (MedCity News)

Data from Closed-Loop Spinal Cord Stimulation Studies to be Presented at INS 14th World Congress in Sydney

May 20, 2019 - Saluda Medial announced new data from multiple studies evaluating the company's closed-loop spinal cord stimulation system will be presented in plenary lectures and oral abstracts during the International Neuromodulation Society 14th World Congress. Also, Saluda CEO John Parker will speak at the pre-congress Innovations in Neuromodulation event, "Disruptive Innovation: The Driving Force of Progress in Neuromodulation". (PR Newswire)

Noninvasive Stimulation Under Study for Migraine Treatment

May 20, 2019 - Theranica Bio-Electronics is pursuing development of a stimulator worn on the upper arm to potentially provide acute migraine treatment. (ISRAEL21c)

Startup Pursuing Neurostimulation for Opioid Withdrawal Wins Technology Competition

May 20, 2019 - Spark Biomedical received $50,000 as first-place winner in the Texas A&M New Ventures Competition for its work to develop a noninvasive neurostimulation treatment for opioid withdrawal and addiction. (My San Antonio)

Meeting Presentation Concerns Vagus Nerve Stimulation in Crohn's Disease

May 20, 2019 - SetPoint Medical announced presentation of a European study of its implanted vagus nerve stimulator in patients with Crohn's Disease. (Globe Newswire)

Collaboration Pursues Closed-Loop Brain Stimulation Approach

May 17, 2019 - At a progress report about DARPA-funded neuroscience technologies, researchers discussed their work to analyze and potentially influence mood-related brain activity, with an ultimate goal of developing a closed-loop neurostimulation system. (IEEE Spectrum)

Study Investigates Deep Brain Stimulation to the Ventral Tegmental Area in Chronic Cluster Headache

May 16, 2019 - An article reports on a study of deep brain stimulation to the ventral tegmental area in patients with refractory chronic cluster headache. (Clinical Pain Advisor)

Visual Prosthesis Company Announces Plans

May 16, 2019 - Second Sight Medical plans to accelerate development of its Orion visual cortical prosthesis system to address various types of vision loss. (Mass Device)

To see select neuromodulation news by category, as well as news about the INS in particular, please visit the Newsroom. To see archived news briefs dating back to January 2011, visit the News Archive.

Continue Reading News Briefs
Last Updated on Monday, December 12, 2016 10:01 AM